SEB vs XENE

Comparison between Seaboard Corp (SEB, Company) and Xenon Pharmaceuticals Inc (XENE, Company).

SEB is from the Industrials sector, while XENE is from the Healthcare sector.

5-Year PerformanceXENE has outperformed SEB, delivering a return of +22.9% compared to +7.4%

SEB vs XENE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	SEB(COMPANY)	XENE(COMPANY)
Market Cap	$4.96B	$4.96B
Max Drawdown	70.28%	90.43%
Sharpe Ratio	1.86	1.00
5Y Beta	0.26	0.95
Industry	Conglomerates	Biotechnology
P/E Ratio	8.42	-11.03
Forward P/E	11.93	N/A
PEG Ratio	0.02	-0.27
Dividend Yield	0.17%	N/A
5Y Dividends CAGR	0.00%	N/A
5Y EPS CAGR	4.77%	40.27%
Debt to Equity	18.25%	0.00%
Free Cash Flow Yield	-0.30%	-6.19%
P/S Ratio	0.51	727.44
P/B Ratio	0.93	3.81

Market Cap

SEB

$4.96B

Winner

XENE

$4.96B

Max Drawdown

Winner

SEB

70.28%

XENE

90.43%

Sharpe Ratio

Winner

SEB

1.86

XENE

1.00

5Y Beta

Winner

SEB

0.26

XENE

0.95

Industry

SEB

Conglomerates

XENE

Biotechnology

P/E Ratio

SEB

8.42

Winner

XENE

-11.03

Forward P/E

SEB

11.93

XENE

N/A

PEG Ratio

SEB

0.02

Winner

XENE

-0.27

Dividend Yield

SEB

0.17%

XENE

N/A

5Y Dividends CAGR

SEB

0.00%

XENE

N/A

5Y EPS CAGR

SEB

4.77%

Winner

XENE

40.27%

Debt to Equity

SEB

18.25%

Winner

XENE

0.00%

Free Cash Flow Yield

Winner

SEB

-0.30%

XENE

-6.19%

P/S Ratio

Winner

SEB

0.51

XENE

727.44

P/B Ratio

Winner

SEB

0.93

XENE

3.81

SEB vs XENE - Historical Returns

Returns include dividend reinvestment.

Period	SEB	XENE
1 month	+14.65%	-5.27%
3 months	+6.47%	-10.02%
6 months	+20.38%	+18.25%
1 year	+93.85%	+58.84%
5 years(CAGR)	+7.38%	+22.87%
10 years(CAGR)	+6.86%	+21.88%
Max(CAGR)	+12.92%	+14.81%

Winner

SEB

+14.65%

XENE

-5.27%

Winner

SEB

+6.47%

XENE

-10.02%

Winner

SEB

+20.38%

XENE

+18.25%

Winner

SEB

+93.85%

XENE

+58.84%

5Y(CAGR)

SEB

+7.38%

Winner

XENE

+22.87%

10Y(CAGR)

SEB

+6.86%

Winner

XENE

+21.88%

Max(CAGR)

SEB

+12.92%

Winner

XENE

+14.81%

SEB vs XENE - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	SEB	XENE
2026	+20.33%	+17.10%
2025	+84.04%	+11.58%
2024	-32.31%	-12.71%
2023	-2.62%	+23.62%
2022	-2.97%	+24.82%
2021	+26.44%	+111.94%
2020	-28.14%	+12.10%
2019	+21.67%	+96.26%
2018	-18.95%	+119.48%
2017	+10.09%	-64.01%
2016	+40.64%	-3.27%
2015	-29.37%	-57.01%
2014	+51.98%	+88.10%
2013	+5.76%	N/A
2012	+18.81%	N/A
2011	+1.65%	N/A
2010	+43.52%	N/A
2009	+11.33%	N/A
2008	-18.97%	N/A
2007	-16.35%	N/A
2006	+19.10%	N/A
2005	+51.45%	N/A
2004	+257.30%	N/A
2003	+18.03%	N/A
2002	-25.90%	N/A
2001	+103.63%	N/A
2000	-21.56%	N/A
1999	-14.68%	N/A

SEB vs XENE Drawdown Comparison

The maximum drawdown for SEB was -70.20%, occurring on Nov 20, 2008. Recovery took 1072 trading sessions.

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The current SEB drawdown is -10.72%. The current XENE drawdown is -16.99%.

Rank	SEB	XENE
#1	-70.20% Apr 20, 2007 - Jul 21, 2011	-90.43% Jan 8, 2015 - Oct 4, 2021
#2	-48.37% Apr 23, 2019 - Nov 26, 2025	-43.59% Feb 9, 2024 - Mar 9, 2026
#3	-46.49% Mar 20, 2015 - Oct 12, 2017	-34.08% May 9, 2023 - Dec 22, 2023
#4	-40.47% Nov 8, 1999 - Jul 12, 2001	-30.14% Nov 5, 2021 - Aug 4, 2022
#5	-39.31% Jan 9, 2002 - Feb 9, 2004	-25.87% Nov 11, 2014 - Dec 11, 2014
#6	-37.72% Jul 21, 2011 - Jan 29, 2013	-18.40% Mar 9, 2026 - Jun 8, 2026
#7	-36.88% Dec 5, 2005 - Jan 8, 2007	-17.08% Mar 1, 2023 - May 3, 2023
#8	-34.02% Jul 8, 2005 - Dec 5, 2005	-16.98% Aug 24, 2022 - Feb 13, 2023
#9	-32.14% Aug 13, 2001 - Dec 7, 2001	-11.44% Oct 15, 2021 - Nov 2, 2021
#10	-31.44% Apr 12, 2005 - May 20, 2005	-11.09% Dec 11, 2014 - Dec 29, 2014
#11	-24.65% Oct 12, 2017 - Apr 18, 2019	-9.36% Feb 13, 2023 - Mar 1, 2023
#12	-24.03% Apr 9, 2026 - May 7, 2026	-8.58% Jan 8, 2024 - Feb 8, 2024
#13	-20.00% Aug 5, 2013 - Jun 24, 2014	-8.27% Aug 10, 2022 - Aug 24, 2022
#14	-19.93% Jul 1, 2014 - Nov 4, 2014	-6.08% Dec 29, 2014 - Jan 7, 2015
#15	-15.88% Sep 21, 2004 - Oct 27, 2004	-4.89% Dec 27, 2023 - Jan 8, 2024